Fairfield Financial Advisors, LTD Roivant Sciences Ltd. Transaction History
Fairfield Financial Advisors, LTD
- $294 Billion
- Q3 2024
A detailed history of Fairfield Financial Advisors, LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 500 shares of ROIV stock, worth $5,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$5,510
Previous $5.29 Million
9.18%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
312Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$727 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$725 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$596 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$459 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$390 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.76B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...